

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and inte⦠read more
Healthcare
Drug ManufacturersāSpecialty & Generic
3 years
USD
Exclusive to Premium users
$10.55
Price+0.67%
$0.07
$624.769m
Small
4.5x
Premium
Premium
+26.8%
EBITDA Margin+10.0%
Net Profit Margin+29.0%
Free Cash Flow Margin+26.8%
EBITDA Margin+10.0%
Net Profit Margin+29.0%
Free Cash Flow Margin$1.080b
-3.8%
1y CAGR-1.4%
3y CAGR-1.9%
5y CAGR$95.400m
+21.0%
1y CAGR-12.1%
3y CAGR-20.6%
5y CAGR$1.62
+20.9%
1y CAGR-12.6%
3y CAGR-21.2%
5y CAGR-$650.600m
$28.300m
Assets$1.742b
Liabilities$1.430b
Debt5054.1%
4.8x
Debt to EBITDA$182.400m
+816.6%
1y CAGR+225.2%
3y CAGR+167.2%
5y CAGR